ClinicalTrials.gg
Not yet recruitingNCT079365911T-VCIUpdated Nov 13, 2026

First-Trimester Ultrasound Assessment of Velamentous Cord Insertion

An observational study in Prenatal Diagnosis, sponsored by Hospital Authority, Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Hospital Authority, Hong Kong · Observational

How we know

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this observational study is to learn whether a short ultrasound assessment during the routine first-trimester pregnancy scan can identify velamentous cord insertion, an abnormal location where the umbilical cord joins the placenta. The study will include pregnant participants aged 18 years or older with a singleton pregnancy who attend first-trimester combined screening between 11+0 and 13+6 weeks of pregnancy.

The main questions it aims to answer are:

  • How often can the placental cord-insertion site be successfully classified within a 3-minute assessment?
  • How accurately does first-trimester ultrasound identify velamentous cord insertion compared with examination of the placenta after delivery?

Participants will:

  • Attend their usual first-trimester ultrasound examination.
  • Have an additional transabdominal ultrasound assessment of the placental cord-insertion site after the routine scan, taking no more than 3 minutes.
  • Allow the study team to review relevant pregnancy and birth records.
  • If they deliver at the study hospital, allow examination of the placenta after delivery as part of the study reference standard.
Read the detailed description

Participants with singleton pregnancies attending first-trimester combined screening between 11+0 and 13+6 weeks will be invited to participate. The research-specific placental cord-insertion assessment will be performed after completion of routine clinical care and will not replace or alter standard ultrasound assessment. The insertion will be initially classified as normal, VCI, or undetermined.

VCI or undetermined examinations will undergo repeat ultrasound assessment in the same setting or within 1 week by maternal-fetal-medicine team, transvaginal ultrasound may be considered to facilitate visualization. If an abnormal insertion is confirmed, subsequent care, including repeat assessment and transvaginal ultrasound for vasa previa where clinically indicated, will follow existing practice.

For participants who deliver at the study hospital, available placentas will undergo blinded structured postnatal gross examination and standardized photographic documentation. The final postnatal placental classification, reviewed by an assessor blinded to antenatal ultrasound classifications and neonatal outcome, will serve as the reference standard for the primary diagnostic-accuracy analysis.

02

Conditions studied

  • Prenatal Diagnosis

Keywords

  • Velamentous cord insertion
  • Placental cord insertion
  • Ultrasonography, Prenatal
  • Prenatal Diagnosis
  • First trimester
03

In context

Lead sponsor

Hospital Authority, Hong Kong is the lead sponsor of 80 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population comprises pregnant participants aged 18 years or older with singleton pregnancies who attend routine first-trimester combined screening at Pamela Youde Nethersole Eastern Hospital Hong Kong between 11+0 and 13+6 weeks of gestation. Participants must have capacity to provide written informed consent. Individuals with multiple pregnancies and those who decline or withdraw consent will not be included. All enrolled participants will undergo the same focused, research-specific transabdominal ultrasound assessment of the placental cord-insertion site after completion of their routine clinical screening examination.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant participants aged 18 years or older with a singleton pregnancy
  • Attendance for first-trimester combined screening at 11+0 to 13+6 weeks
  • Capacity to provide written

Exclusion criteria

Exclusion Criteria:

  • Multiple pregnancy
  • Declined or withdrawn consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Singleton pregnancies undergoing first-trimester placental cord-insertion assessment

    Consenting pregnant participants aged 18 years or older with singleton pregnancies attending first-trimester combined screening at Pamela Youde Nethersole Eastern Hospital Hong Kong at 11+0 to 13+6 weeks gestation. Following routine screening, participants undergo a focused transabdominal placental cord-insertion assessment of up to 3 additional minutes, with review or repeat assessment according to the prespecified pathway where needed.

06

What researchers measure

Primary outcomes

  1. Sensitivity of First-Trimester Ultrasound for Detecting Velamentous Cord Insertion

    Sensitivity of first-trimester ultrasound for detection of velamentous cord insertion

    Time frame: Up to 7 months after the baseline assessment, at postnatal placental examination.

  2. Specificity of First-Trimester Ultrasound for Detecting Velamentous Cord Insertion

    Specificity of first-trimester ultrasound for detection of velamentous cord insertion

    Time frame: Up to 7 months after the baseline assessment, at postnatal placental examination.

  3. Percentage of Participants with a Definitive Classification Within the Initial 3-Minute Ultrasound Assessment

    Proportion of participants classified as either normal placental cord insertion or velamentous cord insertion within the prespecified 3-minute focused ultrasound assessment.

    Time frame: Baseline

  4. Percentage of Participants with a Definitive Classification After Completion of the Assessment Pathway

    Proportion of participants with a final classification of either normal placental cord insertion or velamentous cord insertion after maternal-fetal-medicine review and/or repeat ultrasound assessment, where required.

    Time frame: Up to 1 week after the baseline assessment

Secondary outcomes

  1. Percentage of Participants with an Indeterminate Initial Placental Cord-Insertion Assessment

    Proportion of participants with an indeterminate initial placental cord-insertion classification and documented reasons for indeterminate assessment, if any

    Time frame: Baseline

  2. Neonatal Birth Weight

    Birth weight recorded at delivery, and local gestational age specific centiles where available

    Time frame: At delivery

  3. Gestational age at delivery

    Gestational age in completed weeks at delivery

    Time frame: At delivery

  4. Mode of delivery

    Mode of delivery recorded from maternity records

    Time frame: At delivery

  5. Neonatal Apgar Scores at 1 and 5 Minutes After Birth

    Apgar scores assessed at 1 and 5 minutes after birth. Scores range from 0 to 10, with higher scores indicating better neonatal condition.

    Time frame: At delivery episode, 1 and 5 minutes after birth

  6. NICU admission

    Admission to a neonatal intensive care unit

    Time frame: At delivery episode

Other outcomes

  1. Hypertensive disorders of pregnancy

    Incidence of gestational hypertension, pre-eclampsia, or chronic hypertension with superimposed pre-eclampsia, summarized descriptively according to antenatal and postnatal placental cord-insertion status

    Time frame: From baseline assessment to delivery, up to 7 months

07

Study locations

1 site
08

References and documents

Publications

  • Padula F, Lagana AS, Vitale SG, Mangiafico L, D'Emidio L, Cignini P, Giorlandino M, Gulino FA, Capriglione S, Giorlandino C. Ultrasonographic evaluation of placental cord insertion at different gestational ages in low-risk singleton pregnancies: a predictive algorithm. Facts Views Vis Obgyn. 2016 Mar 28;8(1):3-7. PubMed 27822346 ↗
  • Siargkas A, Tsakiridis I, Pachi C, Mamopoulos A, Athanasiadis A, Dagklis T. Impact of velamentous cord insertion on perinatal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023 Feb;5(2):100812. doi: 10.1016/j.ajogmf.2022.100812. Epub 2022 Nov 12. PubMed 36379439 ↗
  • Derisbourg S, Boulay A, Lamy C, Barlow P, Van Rysselberge M, Thomas D, Rozenberg S, Daelemans C. First trimester ultrasound prediction of velamentous cord insertions: a prospective study. J Matern Fetal Neonatal Med. 2021 Aug;34(16):2642-2648. doi: 10.1080/14767058.2019.1670797. Epub 2019 Sep 26. PubMed 31558066 ↗
  • Sepulveda W, Rojas I, Robert JA, Schnapp C, Alcalde JL. Prenatal detection of velamentous insertion of the umbilical cord: a prospective color Doppler ultrasound study. Ultrasound Obstet Gynecol. 2003 Jun;21(6):564-9. doi: 10.1002/uog.132. PubMed 12808673 ↗
  • Sepulveda W. Velamentous insertion of the umbilical cord: a first-trimester sonographic screening study. J Ultrasound Med. 2006 Aug;25(8):963-8; quiz 970. doi: 10.7863/jum.2006.25.8.963. PubMed 16870889 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared outside the study team because the study involves potentially identifiable pregnancy, ultrasound, placental, and perinatal clinical data held under institutional data-governance and privacy requirements. De-identified aggregate data may be available in publications or on reasonable request, subject to applicable approval and requirements.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jun 2028, 19 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2026
First posted
Nov 13, 2026
StartEst.
Nov 2026
Primary completionEst.
Jun 2028
CompletionEst.
Jun 2028
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07936591
Lead sponsor
Hospital Authority, Hong Kong
Responsible party
Linus Lee (Associate Consultant, Department of Obstetrics and Gynecology, PYN Eastern Hospital, Hospital Authority, Hong Kong) — Principal investigator
First posted
Nov 13, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Nov 13, 2026

Study contacts

Linus Lee
Contact
llt511@ha.org.hk
852-25957359
Linus Lee
principal investigator · Hospital Authority

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion